Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Durham

Showing results (421-430 of 477) with videos related to

Pageof 48
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 22, 2018
BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007)G K Scadding, H H Kariyawasam, G Scadding, et al.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
The Journal of Allergy and Clinical Immunology|November 30, 2010
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) articlePhilippe J Bousquet, Moisés A Calderón, Pascal Demoly, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 18, 2007
BSACI guidelines for the management of allergic and non-allergic rhinitisG K Scadding, S R Durham, R Mirakian, et al.
The Journal of Allergy and Clinical Immunology|December 20, 2015
IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosaEmily P S Lam, Harsha H Kariyawasam, Batika M J Rana, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2021
Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapyMohamed H Shamji, David Larson, Aarif Eifan, et al.
The Journal of Allergy and Clinical Immunology|November 5, 2013
Development of cockroach immunotherapy by the Inner-City Asthma ConsortiumRobert A Wood, Alkis Togias, Jeremy Wildfire, et al.
Allergy|November 14, 2019
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas-An EAACI Task Force ReportOliver Pfaar, Kostas Karatzas, Katharina Bastl, et al.
JAMA|February 15, 2017
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical TrialGuy W Scadding, Moises A Calderon, Mohamed H Shamji, et al.
The Journal of Allergy and Clinical Immunology|July 17, 2023
Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapyMatthew C Altman, R Max Segnitz, David Larson, et al.
Pageof 48

Showing results (421-430 of 477) with videos related to

Sort By:
Pageof 48
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 22, 2018
BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007)G K Scadding, H H Kariyawasam, G Scadding, et al.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
The Journal of Allergy and Clinical Immunology|November 30, 2010
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) articlePhilippe J Bousquet, Moisés A Calderón, Pascal Demoly, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 18, 2007
BSACI guidelines for the management of allergic and non-allergic rhinitisG K Scadding, S R Durham, R Mirakian, et al.
The Journal of Allergy and Clinical Immunology|December 20, 2015
IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosaEmily P S Lam, Harsha H Kariyawasam, Batika M J Rana, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2021
Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapyMohamed H Shamji, David Larson, Aarif Eifan, et al.
The Journal of Allergy and Clinical Immunology|November 5, 2013
Development of cockroach immunotherapy by the Inner-City Asthma ConsortiumRobert A Wood, Alkis Togias, Jeremy Wildfire, et al.
Allergy|November 14, 2019
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas-An EAACI Task Force ReportOliver Pfaar, Kostas Karatzas, Katharina Bastl, et al.
JAMA|February 15, 2017
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical TrialGuy W Scadding, Moises A Calderon, Mohamed H Shamji, et al.
The Journal of Allergy and Clinical Immunology|July 17, 2023
Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapyMatthew C Altman, R Max Segnitz, David Larson, et al.
Pageof 48